REGENERON PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: 9148477000
CIK: 0000872589
EIN: 133444607
State Location: NY
State of Inc.: NY
Tickers:
  • Nasdaq:REGN

Form: 13F-HR

Filing Date: 08 May 2026
Report Date: 31 Mar 2026
Accepted: 08 May 2026 02:09 p.m.
Accession Number: 0001104659-26-057922
Act: 34
File Number: 028-24826
Film Number: 26958382

Documents

Primary Document
Accepted: 08 May 2026 02:09 p.m.